4112 — Hodogaya Chemical Co Balance Sheet
0.000.00%
- ¥24bn
- ¥31bn
- ¥44bn
- 87
- 80
- 29
- 76
Annual balance sheet for Hodogaya Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,877 | 9,447 | 11,454 | 10,487 | 12,965 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11,229 | 11,825 | 12,399 | 12,927 | 12,247 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 25,563 | 30,096 | 34,013 | 36,596 | 38,675 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22,108 | 22,645 | 22,449 | 23,729 | 28,665 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 54,903 | 62,609 | 66,448 | 72,051 | 81,157 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,207 | 11,783 | 11,487 | 12,972 | 14,770 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 20,962 | 23,932 | 25,032 | 29,215 | 33,422 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 33,941 | 38,677 | 41,416 | 42,836 | 47,735 |
Total Liabilities & Shareholders' Equity | 54,903 | 62,609 | 66,448 | 72,051 | 81,157 |
Total Common Shares Outstanding |